Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 11381374 | HLA-DR (HLA-DR) | mastocytosis | NA | NA | NA | unclassified | |
| mastocytosis infiltrates were also immunoreactive for cd45, cd117 (kit), and hla-dr. | |||||||
| 11381374 | HLA-DR (HLA-DR) | mast cell leukemia | NA | NA | NA | unclassified | |
| in an attempt to identify novel diagnostic markers for mast cell (mc)-proliferative disorders, serial bone marrow (bm) sections of 22 patients with mastocytosis (systemic indolent mastocytosis, n = 19; mast cell leukemia [mcl], n = 1; isolated bm mastocytosis, n = 2) were analyzed by immunohistochemistry using antibodies against cd2, cd15, cd29, cd30, cd31, cd34, cd45, cd51, cd56, cd68r, cd117, hla-dr, bcl-2, bcl-x(l), myeloperoxidase (mpo), and tryptase. | |||||||
| 4018904 | HLA (HLA) | hodgkin's lymphoma | Egyptian | NA | NA | unclassified | |
| the value of hla phenotypes in the prognosis of hodgkin's lymphoma. | |||||||
| 16007866 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hodgkin's lymphoma | NA | NA | NA | unclassified | |
| genetic susceptibility to hodgkin's lymphoma associated with the human leukocyte antigen region. | |||||||
| 17119058 | HLA-A (HLA-A) | hodgkin's lymphoma | NA | NA | NA | positive | |
| the human leukocyte antigen class i region is associated with ebv-positive hodgkin's lymphoma: hla-a and hla complex group 9 are putative candidate genes. | |||||||
| 17119058 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hodgkin's lymphoma | NA | NA | NA | unclassified | |
| various studies have indicated that the human leukocyte antigen (hla) region is associated with hodgkin's lymphoma. | |||||||
| 17119058 | HLA-CLASS I (HLA CLASS II) | hodgkin's lymphoma | NA | NA | NA | positive | |
| we recently showed a specific association of the hla class i region with ebv-positive hodgkin's lymphoma cases. | |||||||
| 17119058 | HLA-A (HLA-A) | hodgkin's lymphoma | NA | NA | NA | positive | |
| hla-a represents the most interesting target because of its consistent expression in ebv-positive hodgkin's lymphoma cases and its ability to present ebv-derived peptides to cytotoxic t cells. | |||||||
| 17194665 | HLA-B*27 | hodgkin's lymphoma | NA | baclofen | NA | unclassified | |
| paraneoplastic stiff-person syndrome, heterotopic soft tissue ossification and gonarthritis in a hla b27-positive woman preceding the diagnosis of hodgkin's lymphoma. | |||||||
| 17194665 | HLA-B*27 | stiff-person syndrome | NA | baclofen | NA | unclassified | |
| paraneoplastic stiff-person syndrome, heterotopic soft tissue ossification and gonarthritis in a hla b27-positive woman preceding the diagnosis of hodgkin's lymphoma. | |||||||
Copyright 2024